Global food and nutrition company Archer Daniels Midland (ADM) has launched a new supportive solutions platform designed to cater to the nutritional needs of individuals using glucagon-like peptide-1 (GLP-1) receptor agonists and other anti-obesity medications (AOMs), both active users and those discontinuing them.

The platform leverages its proprietary research and scientific analysis to provide over 25 market-ready concepts that cater to specific issues such as muscle health, gut discomfort, hydration, and appetite management. They are formulated with plant-based ingredients, prebiotic fiber, probiotics, postbiotics, botanical extracts, and sweetening solutions, among other ingredients.

ADM leverages advanced technologies and scientific research to develop customized nutritional solutions tailored to individual needs. The company's approach to personalized nutrition integrates factors such as genetic makeup, lifestyle, and health objectives to provide targeted dietary recommendations.